Oxethazaine
규격
126-27-2CAS 번호
204-780-5EC 번호
2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamideIUPAC 명칭
C28H41N3O3화학식
467.6 g/mol분자량
Oxethazaine; 126-27-2; Oxetacaine; Oxethacaine; Oxaine; Muthesa; Strocain; Oxetacaina; oxethazine; Oxetacainum; Wy-806; WY 806; DTXSID0025818; Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-; FH 099; NSC-758444; Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-; IP8QT76V17; DTXCID605818; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol; N,N-Bis(N-methyl-N-phenyl-tert-butylacetamido)-beta-hydroxyethylamine; 2,2'-((2-Hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methylacetamide); Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methyl-; N-(1,1-dimethyl-2-phenyl-ethyl)-2-[[2-[(1,1-dimethyl-2-phenyl-ethyl)-methyl-amino]-2-oxo-ethyl]-(2-hydroxyethyl)amino]-N-methyl-acetamide; N-(1,1-dimethyl-2-phenyl-ethyl)-2-((2-((1,1-dimethyl-2-phenyl-ethyl)-methyl-amino)-2-oxo-ethyl)-(2-hydroxyethyl)amino)-N-methyl-acetamide; RefChem:857129; C05AD06; 2,2'-((2-hydroxyethyl)imino)bis(N-alpha,alpha-dimethylphenethyl)-N-methylacetamide; 2,2'-(2-Hydroxyethylimino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); 204-780-5; oxetacain; Mucaine; Betalgil; Oxaethacainum; Oxetacaine [INN]; CHEMBL127592; 2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide; Oxetacaine (INN); MFCD00079202; NCGC00016382-01; CAS-126-27-2; 2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); C28H41N3O3; Oxethacaina [Italian]; Milzine; Oxetacainum [INN-Latin]; Oxetacaina [INN-Spanish]; 2,2'-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]; CCRIS 4692; SR-05000001851; EINECS 204-780-5; Oxethazaine [USAN:JAN]; BRN 2404063; UNII-IP8QT76V17; Prestwick_767; Oxethazaine (Standard); Spectrum_001657; OXETHAZAINE [MI]; Prestwick0_000058; Prestwick1_000058; Prestwick2_000058; Prestwick3_000058; Spectrum2_001987; Spectrum3_001751; Spectrum4_000202; Spectrum5_001269; OXETHAZAINE [JAN]; OXETHAZAINE [USAN]; cid_4621; OXETACAINE [MART.]; OXETACAINE [WHO-DD]; Oxethazaine (JP18/USAN); SCHEMBL24489; BSPBio_000215; BSPBio_003482; KBioGR_000803; KBioSS_002137; 4-12-00-02822 (Beilstein Handbook Reference); MLS002154188; DivK1c_000715; SPECTRUM1503279; SPBio_002136; SPBio_002173; BPBio1_000237; orb1226646; orb1310992; Oxethazaine, analytical standard; CHEBI:31947; HMS502D17; HY-B0955R; KBio1_000715; KBio2_002137; KBio2_004705; KBio2_007273; KBio3_002702; NINDS_000715; HMS1568K17; HMS1922A04; HMS2093C15; HMS2095K17; HMS2236A03; HMS3370M13; HMS3712K17; HMS3885P21; HMS5083A13; Pharmakon1600-01503279; HY-B0955; MSK10514; Tox21_110407; BDBM50017672; CCG-39525; EBC-27170; NSC758444; AKOS024284189; Tox21_110407_1; CS-4432; DB12532; FO26625; NSC 758444; IDI1_000715; NCGC00016382-02; NCGC00016382-03; NCGC00016382-04; NCGC00016382-07; NCGC00016382-09; NCGC00095039-01; NCGC00095039-02; NCGC00095039-03; 2-[(2-hydroxyethyl)({[methyl(2-methyl-1-phenylpropan-2-yl)carbamoyl]methyl})amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide; MS-28631; SMR001233479; ST073363; SY491470; SBI-0051816.P002; DB-041818; AB00052348; NS00010381; SW196906-3; T0044; D01152; G12282; AB00052348_08; AB00052348_09; EN300-26506802; Q2412605; SR-05000001851-1; SR-05000001851-3; BRD-K56940463-001-05-4; BRD-K56940463-001-08-8; BRD-K56940463-001-13-8; BRD-K56940463-001-14-6; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)amino ethanol; 2,2'-[(2-Hydroxyethyl)azanediyl]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide]; 2,2 inverted exclamation marka-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]; 2,2'-((2-HYDROXYETHYL)IMINO)BIS(N-(.ALPHA.,.ALPHA.-DIMETHYLPHENETHYL)-N-METHYLACETAMIDE); N-(1,1-Dimethyl-2-phenyl-ethyl)-2-[{[(1,1-dimethyl-2-phenyl-ethyl)-methyl-carbamoyl]-methyl}-(2-hydroxy-ethyl)-amino]-N-methyl-acetamide; N-(1,1-dimethyl-2-phenylethyl)-2-({[N-(1,1-dimethyl-2-phenylethyl)-N-methylcar bamoyl]methyl}(2-hydroxyethyl)amino)-N-methylacetamide; Oxetacain (Oxethazin)동의어
Oxethazaine 함유 제품
위그린정가스트릴정일양쓰리쏙정툴스속편정넥시겔현탁액(수출명: Nexigel suspension)(수출용)바루돈현탁액(수출용)알미틴플러스정위모닝정노시드정트립겔현탁액(수출용)포세라정프리번정
1/4 페이지
Oxethazaine 판매 기업
CT
Công ty TNHH BRV HealthcareViet Nam한림
한림제약(주)Republic of Korea(주
(주)테라젠이텍스Republic of Korea일양
일양약품(주)Republic of Korea(주
(주)넥스팜코리아Republic of Korea영진
영진약품(주)Republic of Korea메딕
메딕스제약(주)Republic of KoreaDP
Daewon Pharmaceutical Co., Ltd.Republic of Korea1/3 페이지